Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.

@article{CarrilloMunoz2002CiclopiroxolamineIV,
  title={Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.},
  author={A. J. Carrillo-Munoz and Sonia Bri{\'o} and Roc{\'i}o Alonso and Oscar del Valle and Perp{\'e}tua Santos and Guillermo Quind{\'o}s},
  journal={International journal of antimicrobial agents},
  year={2002},
  volume={20 5},
  pages={
          375-9
        }
}
The in vitro susceptibility of 225 clinical isolates of yeasts to ciclopiroxolamine (CPO) was compared with that of clotrimazole, econazole, ketoconazole, miconazole, tioconazole, fluconazole, itraconazole and nystatin using a standardized agar diffusion method (NeoSensitabs). Two hundred and eight strains of yeasts comprising 16 species of Candida and 22 strains belonging to other yeast genera were tested. One strain (0.4%) was resistant, four strains (1.8%) of intermediate susceptibility and… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Antifungal Therapeutic Failure – Need for a More Comprehensive Review

  • Indian journal of dermatology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND